This bill allows pharmacists in New Jersey to dispense HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) without an individual prescription, contingent upon specific conditions such as completion of a training program and a standing order from the Commissioner of Health. Pharmacists must ensure patients are HIV negative and do not show symptoms of acute HIV infection before dispensing PrEP, and they are required to provide counseling and notify the patient's primary care provider unless consent is withheld. For PEP, pharmacists can provide a complete course if the exposure occurred within the last 72 hours and the patient meets clinical criteria. The bill limits the supply of PrEP dispensed by pharmacists to a maximum of 90 days within a two-year period.

Additionally, the legislation mandates that health insurance policies, including Medicaid and state employee health plans, cover PrEP and PEP without prior authorization or step therapy requirements, although they may impose such requirements on therapeutic equivalents if at least one version is covered without them. Reimbursements to pharmacists for these services must be at least equal to those provided to other non-physician practitioners, and pharmacists will have the same rights of participation in health plans as other healthcare providers. The bill also provides civil liability protection for pharmacists acting in good faith under these provisions, thereby enhancing access to HIV prevention and treatment while ensuring equitable treatment for pharmacists in the healthcare system.